Studies have demonstrated a significant increase in TBRG4 expression in patients with head and neck squamous cell carcinoma and in the tumor tissues of multiple myeloma patients with extramedullary recurrence [10, 11]. This evidence concerns the gene TBRG4 and neoplasm.